![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dimethylhydrazine | multiple interactions | ISO | RGD:1558191 | 6480464 | [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of HUNK mRNA | CTD | PMID:22206623 | 1,2-dimethylhydrazine | decreases expression | ISO | RGD:1558191 | 6480464 | 1, 2-Dimethylhydrazine results in decreased expression of HUNK mRNA | CTD | PMID:22206623 | 17alpha-ethynylestradiol | increases expression | ISO | RGD:1558191 | 6480464 | Ethinyl Estradiol results in increased expression of HUNK mRNA | CTD | PMID:17942748 | 17beta-estradiol | increases expression | ISO | RGD:1558191 | 6480464 | Estradiol results in increased expression of HUNK mRNA | CTD | PMID:19484750 | 2,2',4,4',5,5'-hexachlorobiphenyl | multiple interactions | ISO | RGD:1558191 | 6480464 | [2 more ... | CTD | PMID:25510870 | 2,2',5,5'-tetrachlorobiphenyl | multiple interactions | ISO | RGD:1558191 | 6480464 | [2 more ... | CTD | PMID:25510870 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1558191 | 6480464 | AHR protein affects the reaction [Tetrachlorodibenzodioxin results in increased expression of HUNK mRNA] | CTD | PMID:16214954 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1344314 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of HUNK mRNA | CTD | PMID:27913140 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1558191 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of HUNK mRNA | CTD | PMID:25975270, PMID:26290441 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1558191 | 6480464 | Tetrachlorodibenzodioxin affects the expression of HUNK mRNA | CTD | PMID:26377647 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1558191 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of HUNK mRNA | CTD | PMID:16214954 | 3,3',5-triiodo-L-thyronine | increases expression | ISO | RGD:1558191 | 6480464 | Triiodothyronine results in increased expression of HUNK mRNA | CTD | PMID:25172293 | 3,4-methylenedioxymethamphetamine | increases expression | ISO | RGD:1558191 | 6480464 | N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of HUNK mRNA | CTD | PMID:20188158 | 4,4'-sulfonyldiphenol | decreases methylation | ISO | RGD:1344314 | 6480464 | bis(4-hydroxyphenyl)sulfone results in decreased methylation of HUNK gene | CTD | PMID:31601247 | 4,4'-sulfonyldiphenol | affects methylation | ISO | RGD:1558191 | 6480464 | bis(4-hydroxyphenyl)sulfone affects the methylation of HUNK gene | CTD | PMID:31683443 | 4-hydroxyphenyl retinamide | increases expression | ISO | RGD:1558191 | 6480464 | Fenretinide results in increased expression of HUNK mRNA | CTD | PMID:28973697 | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of HUNK mRNA | CTD | PMID:24780913 | acrylamide | increases expression | ISO | RGD:1344314 | 6480464 | Acrylamide results in increased expression of HUNK mRNA | CTD | PMID:32763439 | aflatoxin B1 | increases methylation | ISO | RGD:1344314 | 6480464 | Aflatoxin B1 results in increased methylation of HUNK intron | CTD | PMID:30157460 | aldehydo-D-glucose | multiple interactions | ISO | RGD:1558191 | 6480464 | fucoxanthin inhibits the reaction [Glucose results in decreased expression of HUNK mRNA] | CTD | PMID:33448797 | aldehydo-D-glucose | decreases expression | ISO | RGD:1558191 | 6480464 | Glucose results in decreased expression of HUNK mRNA | CTD | PMID:33448797 | all-trans-retinoic acid | increases expression | ISO | RGD:1344314 | 6480464 | Tretinoin results in increased expression of HUNK mRNA | CTD | PMID:21934132 | all-trans-retinoic acid | decreases expression | ISO | RGD:1344314 | 6480464 | Tretinoin results in decreased expression of HUNK mRNA | CTD | PMID:33167477 | antirheumatic drug | increases expression | ISO | RGD:1344314 | 6480464 | Antirheumatic Agents results in increased expression of HUNK mRNA | CTD | PMID:24449571 | aristolochic acid A | decreases expression | ISO | RGD:1344314 | 6480464 | aristolochic acid I results in decreased expression of HUNK mRNA | CTD | PMID:33212167 | belinostat | decreases expression | ISO | RGD:1344314 | 6480464 | belinostat results in decreased expression of HUNK mRNA | CTD | PMID:27188386 | benzo[a]pyrene | increases expression | ISO | RGD:1558191 | 6480464 | Benzo(a)pyrene results in increased expression of HUNK mRNA | CTD | PMID:27195522 | benzo[a]pyrene | increases methylation | ISO | RGD:1558191 | 6480464 | Benzo(a)pyrene results in increased methylation of HUNK intron | CTD | PMID:27901495 | benzo[a]pyrene | multiple interactions | ISO | RGD:1558191 | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of HUNK mRNA | CTD | PMID:27858113 | benzo[a]pyrene | increases methylation | ISO | RGD:1344314 | 6480464 | Benzo(a)pyrene results in increased methylation of HUNK exon, Benzo(a)pyrene results in increased methylation of HUNK promoter | CTD | PMID:27901495 | benzo[b]fluoranthene | increases expression | ISO | RGD:1558191 | 6480464 | benzo(b)fluoranthene results in increased expression of HUNK mRNA | CTD | PMID:26377693 | benzo[b]fluoranthene | multiple interactions | ISO | RGD:1558191 | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of HUNK mRNA | CTD | PMID:27858113 | benzo[e]pyrene | decreases methylation | ISO | RGD:1344314 | 6480464 | benzo(e)pyrene results in decreased methylation of HUNK promoter | CTD | PMID:30157460 | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Testosterone] results in increased expression of HUNK mRNA | CTD | PMID:26496021 | bisphenol A | decreases expression | ISO | RGD:1344314 | 6480464 | bisphenol A results in decreased expression of HUNK mRNA | CTD | PMID:33670352 | bisphenol F | multiple interactions | ISO | RGD:1344314 | 6480464 | [bisphenol F co-treated with Fulvestrant] results in increased methylation of HUNK gene | CTD | PMID:31601247 | cadmium dichloride | increases expression | EXP | | 6480464 | Cadmium Chloride results in increased expression of HUNK mRNA | CTD | PMID:33453195 | chlordecone | multiple interactions | ISO | RGD:1558191 | 6480464 | Chlordecone promotes the reaction [Biomarkers metabolite binds to HUNK gene] | CTD | PMID:31084621 | chlorpyrifos | increases expression | ISO | RGD:1558191 | 6480464 | Chlorpyrifos results in increased expression of HUNK mRNA | CTD | PMID:37019170 | chrysene | multiple interactions | ISO | RGD:1558191 | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of HUNK mRNA | CTD | PMID:27858113 | D-glucose | decreases expression | ISO | RGD:1558191 | 6480464 | Glucose results in decreased expression of HUNK mRNA | CTD | PMID:33448797 | D-glucose | multiple interactions | ISO | RGD:1558191 | 6480464 | fucoxanthin inhibits the reaction [Glucose results in decreased expression of HUNK mRNA] | CTD | PMID:33448797 | dibenz[a,h]anthracene | increases expression | ISO | RGD:1558191 | 6480464 | 1 more ... | CTD | PMID:26377693 | dichloroacetic acid | increases expression | ISO | RGD:1558191 | 6480464 | Dichloroacetic Acid results in increased expression of HUNK mRNA | CTD | PMID:28962523 | diuron | increases expression | EXP | | 6480464 | Diuron results in increased expression of HUNK mRNA | CTD | PMID:21551480 | doxorubicin | decreases expression | ISO | RGD:1344314 | 6480464 | Doxorubicin results in decreased expression of HUNK mRNA | CTD | PMID:29803840 | ethanol | decreases expression | ISO | RGD:1558191 | 6480464 | Ethanol results in decreased expression of HUNK mRNA | CTD | PMID:29018328 | ethanol | affects expression | ISO | RGD:1558191 | 6480464 | Ethanol affects the expression of HUNK mRNA | CTD | PMID:30319688 | folic acid | multiple interactions | ISO | RGD:1558191 | 6480464 | [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of HUNK mRNA | CTD | PMID:22206623 | fonofos | increases methylation | ISO | RGD:1344314 | 6480464 | Fonofos results in increased methylation of HUNK promoter | CTD | PMID:22847954 | fucoxanthin | multiple interactions | ISO | RGD:1558191 | 6480464 | fucoxanthin inhibits the reaction [Glucose results in decreased expression of HUNK mRNA] | CTD | PMID:33448797 | fulvestrant | multiple interactions | ISO | RGD:1344314 | 6480464 | [bisphenol F co-treated with Fulvestrant] results in increased methylation of HUNK gene | CTD | PMID:31601247 | glucose | decreases expression | ISO | RGD:1558191 | 6480464 | Glucose results in decreased expression of HUNK mRNA | CTD | PMID:33448797 | glucose | multiple interactions | ISO | RGD:1558191 | 6480464 | fucoxanthin inhibits the reaction [Glucose results in decreased expression of HUNK mRNA] | CTD | PMID:33448797 | methapyrilene | decreases methylation | ISO | RGD:1344314 | 6480464 | Methapyrilene results in decreased methylation of HUNK promoter | CTD | PMID:30157460 | methoxychlor | affects methylation | EXP | | 6480464 | Methoxychlor affects the methylation of HUNK gene | CTD | PMID:35440735 | ozone | multiple interactions | ISO | RGD:1558191 | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of HUNK mRNA | CTD | PMID:34911549 | paracetamol | affects expression | ISO | RGD:1558191 | 6480464 | Acetaminophen affects the expression of HUNK mRNA | CTD | PMID:17562736 | parathion | increases methylation | ISO | RGD:1344314 | 6480464 | Parathion results in increased methylation of HUNK promoter | CTD | PMID:22847954 | PCB138 | multiple interactions | ISO | RGD:1558191 | 6480464 | [2 more ... | CTD | PMID:25510870 | phenobarbital | multiple interactions | ISO | RGD:1558191 | 6480464 | NR1I3 protein affects the reaction [Phenobarbital results in increased expression of HUNK mRNA] | CTD | PMID:19482888 | phenobarbital | affects expression | ISO | RGD:1558191 | 6480464 | Phenobarbital affects the expression of HUNK mRNA | CTD | PMID:23091169 | phenobarbital | increases expression | ISO | RGD:1558191 | 6480464 | Phenobarbital results in increased expression of HUNK mRNA | CTD | PMID:19482888 | pirinixic acid | multiple interactions | ISO | RGD:1344314 | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of HUNK mRNA | CTD | PMID:19710929 | pirinixic acid | increases expression | ISO | RGD:1558191 | 6480464 | pirinixic acid results in increased expression of HUNK mRNA | CTD | PMID:18301758, PMID:23811191 | sodium arsenite | decreases expression | ISO | RGD:1558191 | 6480464 | sodium arsenite results in decreased expression of HUNK mRNA | CTD | PMID:36209798 | sotorasib | multiple interactions | ISO | RGD:1344314 | 6480464 | [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of HUNK mRNA | CTD | PMID:36139627 | succimer | multiple interactions | ISO | RGD:1558191 | 6480464 | [Succimer binds to Magnetite Nanoparticles] which results in increased expression of HUNK mRNA | CTD | PMID:21641980 | sunitinib | decreases expression | ISO | RGD:1344314 | 6480464 | Sunitinib results in decreased expression of HUNK mRNA | CTD | PMID:31533062 | terbufos | increases methylation | ISO | RGD:1344314 | 6480464 | terbufos results in increased methylation of HUNK promoter | CTD | PMID:22847954 | testosterone | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Testosterone] results in increased expression of HUNK mRNA | CTD | PMID:26496021 | tetraphene | increases expression | ISO | RGD:1558191 | 6480464 | benz(a)anthracene results in increased expression of HUNK mRNA | CTD | PMID:26377693 | tetraphene | multiple interactions | ISO | RGD:1558191 | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of HUNK mRNA | CTD | PMID:27858113 | trametinib | multiple interactions | ISO | RGD:1344314 | 6480464 | [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of HUNK mRNA | CTD | PMID:36139627 | trichloroethene | increases expression | ISO | RGD:1558191 | 6480464 | Trichloroethylene results in increased expression of HUNK mRNA | CTD | PMID:25549359 | trimellitic anhydride | decreases expression | ISO | RGD:1558191 | 6480464 | trimellitic anhydride results in decreased expression of HUNK mRNA | CTD | PMID:19042947 | triptonide | increases expression | ISO | RGD:1558191 | 6480464 | triptonide results in increased expression of HUNK mRNA | CTD | PMID:33045310 | urethane | decreases expression | ISO | RGD:1344314 | 6480464 | Urethane results in decreased expression of HUNK mRNA | CTD | PMID:28818685 | valproic acid | affects expression | ISO | RGD:1558191 | 6480464 | Valproic Acid affects the expression of HUNK mRNA | CTD | PMID:17292431, PMID:17963808 | valproic acid | decreases expression | ISO | RGD:1558191 | 6480464 | Valproic Acid results in decreased expression of HUNK mRNA | CTD | PMID:20546886 | valproic acid | increases methylation | ISO | RGD:1344314 | 6480464 | Valproic Acid results in increased methylation of HUNK gene | CTD | PMID:29154799 | valproic acid | increases expression | ISO | RGD:1344314 | 6480464 | Valproic Acid results in increased expression of HUNK mRNA | CTD | PMID:23179753, PMID:24935251 | valproic acid | affects expression | ISO | RGD:1344314 | 6480464 | Valproic Acid affects the expression of HUNK mRNA | CTD | PMID:25979313 | valproic acid | decreases expression | ISO | RGD:1344314 | 6480464 | Valproic Acid results in decreased expression of HUNK mRNA | CTD | PMID:28001369 | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of HUNK mRNA | CTD | PMID:29427782 | |